Cargando…
Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation
U2 Small Nuclear RNA Auxiliary Factor 1 (U2AF1) forms a heterodimeric complex with U2AF2 that is primarily responsible for 3ʹ splice site selection. U2AF1 mutations have been identified in most cancers but are prevalent in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML), and the most...
Autores principales: | Akef, Abdalla, McGraw, Kathy, Cappell, Steven D., Larson, Daniel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660540/ https://www.ncbi.nlm.nih.gov/pubmed/33137094 http://dx.doi.org/10.1371/journal.pbio.3000920 |
Ejemplares similares
-
Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019) -
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
por: Esfahani, Mohammad S., et al.
Publicado: (2019) -
An ERK1/2‐driven RNA‐binding switch in nucleolin drives ribosome biogenesis and pancreatic tumorigenesis downstream of RAS oncogene
por: Azman, Muhammad S, et al.
Publicado: (2023) -
The U2AF1(S34F) mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
por: Yip, Bon Ham, et al.
Publicado: (2017) -
The Specificity of Downstream Signaling for A(1) and A(2A)R Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength
por: Jain, Abhinav R., et al.
Publicado: (2020)